- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.04. | Prenetics Global Limited: Prenetics' IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One | 5 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics gewinnt NBA-Star Giannis Antetokounmpo als neuen Aktionär und Partner | 5 | Investing.com Deutsch | ||
| 02.04. | Prenetics Global Limited: Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 01.04. | Prenetics Global (PRE) Partners with Superpower on Diagnostics and Supplements | 5 | Insider Monkey | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 24.03. | Prenetics Global Limited: Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation | 3 | GlobeNewswire (USA) | ||
| 06.03. | Prenetics: Aktienrückkaufprogramm über 40 Mio. USD treibt Kurs an | 2 | Investing.com Deutsch | ||
| 06.03. | Prenetics Global Board Authorizes Share Repurchase Program | - | RTTNews | ||
| 06.03. | Prenetics rises on $40M share buyback program | 1 | Seeking Alpha | ||
| 06.03. | Prenetics announces $40M share buyback program | 1 | Investing.com | ||
| 06.03. | Prenetics Global Limited: Prenetics Authorizes $40 Million Share Repurchase Program | 1 | GlobeNewswire (USA) | ||
| 03.03. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.03. | Prenetics executives purchase $1.3M in company shares | 3 | Investing.com | ||
| 23.02. | Prenetics Global Limited: Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours | 1 | GlobeNewswire (USA) | ||
| 18.02. | Prenetics veräußert Insighta-Beteiligung für 70 Millionen US-Dollar an Tencent | 15 | Investing.com Deutsch | ||
| 18.02. | Prenetics Global Limited: Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR in 12 Months, Revenue Surges 480% YoY | 739 | GlobeNewswire (Europe) | Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic... ► Artikel lesen | |
| 17.02. | Prenetics appoints longevity expert Dr. Darshan Shah to board | 3 | Investing.com | ||
| 17.02. | Prenetics Global Limited: Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors | 843 | GlobeNewswire (Europe) | Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 17.02. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.02. | Prenetics Global Limited: Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity | 1.012 | GlobeNewswire (Europe) | Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026... ► Artikel lesen |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 600,40 | -0,35 % | Biotech-Player: Zelltherapie als Comeback-Story im Milliardenmarkt. Neue Ideen nach Corona von BioNTech, Qiagen und Biotech AG | ||
| VIKING THERAPEUTICS | 25,600 | -3,58 % | Viking Therapeutics, Inc.: Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Conference call scheduled for 4:30 p.m. ET today
-- Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity Advance; VANQUISH-1 and VANQUISH-2 Trials Fully Enrolled... ► Artikel lesen | |
| CANSINO BIOLOGICS | 3,180 | 0,00 % | CanSino Biologics Inc: CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion | HONG KONG, Apr 28, 2026 - (ACN Newswire) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled... ► Artikel lesen | |
| SINO BIOPHARM | 0,610 | +1,24 % | SBP GROUP (01177): NEXT DAY DISCLOSURE RETURN | ||
| GUARDANT HEALTH | 69,55 | -6,27 % | Guardant Health und Nuvalent schließen Partnerschaft für Krebsdiagnostik | ||
| GENSCRIPT BIOTECH | 1,480 | 0,00 % | GenScript Biotech Corporation: GenScript Leaders Named Entrepreneur Of The Year 2026 New Jersey Finalists | PISCATAWAY, N.J., April 22, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the... ► Artikel lesen | |
| BIO-TECHNE | 46,570 | -1,21 % | Bio-Techne Corporation: Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 9,796 | +7,40 % | INNOVENT BIO 1Q26 Product Revenue Exceeds RMB3.8 billion, Up Over 50% YoY | ||
| QUANTUM-SI | 0,960 | -2,10 % | Quantum-Si meldet Durchbruch bei Proteinsequenzierung mit Proteus-System | ||
| SCILEX | 9,200 | +1,66 % | Datavault AI Inc: Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform | Combined with the anticipated sale of the BTC and Receivable collections, Datavault AI projects $200M+ infusion of cash without equity dilution.Datavault AI has previously secured and in stock of Nvidia... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,970 | -1,02 % | Origin Agritech Limited: Origin Agritech Announces Fiscal Year 2025 Results | Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025
BEIJING, Jan. 30, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or... ► Artikel lesen | |
| AKESO | 14,765 | -2,44 % | Summit Therapeutics falls after update on Akeso-partnered lung cancer trial | ||
| HARMONY BIOSCIENCES | 31,840 | +1,86 % | H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook | ||
| SUMMIT THERAPEUTICS | 16,115 | -24,94 % | Summit Therapeutics Inc. - 10-Q, Quarterly Report | ||
| ERASCA | 10,000 | -6,10 % | Erasca, Inc.: Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors | Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE Robust monotherapy efficacy in 2L... ► Artikel lesen |
PRENETICS GLOBAL LIMITED gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 17,020 Euro und damit +1,86 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.